Yuanyuan T. Luo
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Canagliflozin Alleviates Diabetic Glomerular Endothelial Injury via Melibiose in a Microbiota-Dependent Manner.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 03, 2025
Development and validation of a prediction score for subtype diagnosis of primary aldosteronism.
Journal: Chinese medical journal
Published: December 21, 2024
Phased T2T genome assemblies facilitate the mining of disease-resistance genes in Vitis davidii.
Journal: Horticulture research
Published: April 16, 2024
Metabolomics in diabetic nephropathy: Unveiling novel biomarkers for diagnosis (Review).
Journal: Molecular medicine reports
Published: March 22, 2024
Exploring the role of mitochondrial-associated and peripheral neuropathy genes in the pathogenesis of diabetic peripheral neuropathy.
Journal: BMC neurology
Published: November 19, 2023
Selective sodium-glucose cotransporter-2 inhibitors in the improvement of hemoglobin and hematocrit in patients with type 2 diabetes mellitus: a network meta-analysis.
Journal: Frontiers in endocrinology
Published: November 05, 2023
Epidemiological trend of early-onset gastric cancer and late-onset gastric cancer in China from 2000 to 2019
Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
Published: September 04, 2023
Canagliflozin regulates metabolic reprogramming in diabetic kidney disease by inducing fasting-like and aestivation-like metabolic patterns.
Journal: Diabetologia
Published: August 14, 2023
Canagliflozin improves fatty acid oxidation and ferroptosis of renal tubular epithelial cells via FOXA1-CPT1A axis in diabetic kidney disease.
Journal: Molecular and cellular endocrinology
Published: August 01, 2023
ERCC5, HES6 and RORA are potential diagnostic markers of coronary artery disease.
Journal: FEBS open bio
Published: April 06, 2022
Analysis of MEN1 c.482G>A (p.Gly161Asp) mutation in a pedigree with familial multiple endocrine neoplasia type 1.
Journal: Molecular medicine reports
Published: March 31, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026